Abnormal platelet aggregation in pediatric pulmonary hypertension

Endogenous prostacyclin stimulates pulmonary vasodilation and inhibits platelet aggregation. For the synthetic analog treprostinil, used in the treatment of pulmonary hypertension (PH), conflicting, anecdotal evidence exists regarding its effects on clinically relevant platelet function. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Handler, Stephanie S., Jin, Jing, Ogawa, Michelle T., Feinstein, Jeffrey A., Lo, Clara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294293/
https://www.ncbi.nlm.nih.gov/pubmed/35864911
http://dx.doi.org/10.1002/pul2.12104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294293/
https://www.ncbi.nlm.nih.gov/pubmed/35864911
http://dx.doi.org/10.1002/pul2.12104

Ejemplares similares